Continuous Glucose Monitoring (CGM)

Diabetes studies is one of the largest ongoing clinical trial study areas. Continuous glucose monitoring (CGM) is vital for measuring glucose levels with patients and volunteers.

Get in touch with your requirements

Dexcom G6, G6 Pro and G7 devices are popular, FDA approved, reliable and accurate CGM product which has been used to provide key study results at clinical trials worldwide. Woodley Trial Solutions are proud to be an authorised supplier of Dexcom CGM devices.

Need products and equipment for your clinical trial?

We have excellent availability.

See our product range

Woodley Trial Solutions and Dexcom began our partnership in 2019. Since the partnership began, Dexcom G6 has played an important role in many diabetes clinical studies worldwide.

It is the first integrated CGM system which has gained FDA approval and does not require fingerstick calibration. The data can be synched to a cellular device or the Dexcom touchscreen receiver for patient monitoring.

The Dexcom G6, G6 Pro and G7 connect as a wearable device, which continuously monitors glucose levels and provides real-time patient welfare data.

Register your interest in utilizing Dexcom CGM devices for your clinical trial here.

Why partner with us?

Products and equipment for your clinical trial

Find devices and equipment for your clinical study here. If you can’t find what you need, please let us know your requirements and we will reply ASAP.

Popular

Dexcom G6

The G6 is the first integrated CGM system to be approved by the FDA. The revolutionary G6 integrated CGM system that does not require fingerstick calibration.

Popular

Dexcom G7

The Dexcom G7 is best for people with T1 diabetes who may need extra support, such as people who are hypo unaware or children.

Dexcom G6 Pro

The Dexcom G6 Pro Continuous Glucose Monitoring (CGM) System is a tool which provides practice-owned diabetes management with Dexcom G6 CGM System accuracy.